230 related articles for article (PubMed ID: 22723846)
1. Differences in immunoglobulin light chain species found in urinary exosomes in light chain amyloidosis (Al).
Ramirez-Alvarado M; Ward CJ; Huang BQ; Gong X; Hogan MC; Madden BJ; Charlesworth MC; Leung N
PLoS One; 2012; 7(6):e38061. PubMed ID: 22723846
[TBL] [Abstract][Full Text] [Related]
2. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
3. Screening and differential diagnosis of renal light chain-associated diseases.
Gerth J; Sachse A; Busch M; Illner N; Muegge LO; Gröne HJ; Wolf G
Kidney Blood Press Res; 2012; 35(2):120-8. PubMed ID: 22056791
[TBL] [Abstract][Full Text] [Related]
4. Serum free light chains in the diagnosis and monitoring of patients with plasma cell dyscrasias.
Mayo MM; Johns GS
Contrib Nephrol; 2007; 153():44-65. PubMed ID: 17075223
[TBL] [Abstract][Full Text] [Related]
5. Assessment of renal response with urinary exosomes in patients with AL amyloidosis: A proof of concept.
Ramirez-Alvarado M; Barnidge DR; Murray DL; Dispenzieri A; Marin-Argany M; Dick CJ; Cooper SA; Nasr SH; Ward CJ; Dasari S; Jiménez-Zepeda VH; Leung N
Am J Hematol; 2017 Jun; 92(6):536-541. PubMed ID: 28295502
[TBL] [Abstract][Full Text] [Related]
6. Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis.
Decourt A; Gondouin B; Delaroziere JC; Brunet P; Sallée M; Burtey S; Dussol B; Ivanov V; Costello R; Couchoud C; Jourde-Chiche N
Clin J Am Soc Nephrol; 2016 Mar; 11(3):431-41. PubMed ID: 26728585
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal gammopathy: significance and possible causality in renal disease.
Paueksakon P; Revelo MP; Horn RG; Shappell S; Fogo AB
Am J Kidney Dis; 2003 Jul; 42(1):87-95. PubMed ID: 12830460
[TBL] [Abstract][Full Text] [Related]
8. [Usefulness of a free light chain immunoassay in serum for the diagnosis and the follow-up of monoclonal gammopathy].
Guenet L; Decaux O; Lechartier H; Ropert M; Grosbois B
Rev Med Interne; 2007 Oct; 28(10):689-97. PubMed ID: 17566612
[TBL] [Abstract][Full Text] [Related]
9. Serum-free light-chain assay: clinical utility and limitations.
Bhole MV; Sadler R; Ramasamy K
Ann Clin Biochem; 2014 Sep; 51(Pt 5):528-42. PubMed ID: 24489083
[TBL] [Abstract][Full Text] [Related]
10. [The concurrence of light-chain deposition disease, AL-amyloidosis, and cast nephropathy in a patient with multiple myeloma].
Rekhtina IG; Zakharova EV; Stolyarevich ES; Sinitsina MN; Denisova EN
Ter Arkh; 2015; 87(6):98-101. PubMed ID: 26281203
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and treatment of kidney involvement in plasma cell diseases : Renal involvement in multiple myeloma and monoclonal gammopathies].
Gödecke V; Schmidt JJ; Bräsen JH; Koenecke C; Haller H
Internist (Berl); 2019 Jan; 60(1):10-22. PubMed ID: 30635666
[TBL] [Abstract][Full Text] [Related]
12. Fibrillary glomerulopathy secondary to light chain deposition disease in a patient with monoclonal gammopathy.
Sundaram S; Mainali R; Norfolk ER; Shaw JH; Zhang PL
Ann Clin Lab Sci; 2007; 37(4):370-4. PubMed ID: 18000296
[TBL] [Abstract][Full Text] [Related]
13. Benefits of new immunoglobulin-derived biomarkers for the diagnosis and follow-up of patients with dysglobulinemia.
Ermak N; Nguyen-Khoa T; Alyanakian MA
Ann Biol Clin (Paris); 2016 Oct; 74(5):597-605. PubMed ID: 27707674
[TBL] [Abstract][Full Text] [Related]
14. Renal involvement in plasma cell dyscrasias.
Sanders PW
Curr Opin Nephrol Hypertens; 1993 Mar; 2(2):246-52. PubMed ID: 7922184
[TBL] [Abstract][Full Text] [Related]
15. Renal manifestations of plasma cell dyscrasias: an appraisal from the patients' bedside to the research laboratory.
Herrera GA
Ann Diagn Pathol; 2000 Jun; 4(3):174-200. PubMed ID: 10919389
[TBL] [Abstract][Full Text] [Related]
16. Crystals, crystals everywhere but not a clue till late… Light chain crystalline proximal tubulopathy with concomitant myeloma cast nephropathy.
Matthai SM; Alexander S; Jacob S; Duhli N; David VG; Varughese S
Indian J Pathol Microbiol; 2020; 63(3):463-466. PubMed ID: 32769341
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis.
Bochtler T; Hegenbart U; Heiss C; Benner A; Cremer F; Volkmann M; Ludwig J; Perz JB; Ho AD; Goldschmidt H; Schonland SO
Haematologica; 2008 Mar; 93(3):459-62. PubMed ID: 18287137
[TBL] [Abstract][Full Text] [Related]
18. Rapid Deterioration of the Renal Function Caused by the Coexistence of Intratubular Amyloidosis and Myeloma Cast Nephropathy.
Kato H; Fujigaki Y; Asakawa S; Yamaguchi Y; Uozaki H; Komatsuda A; Nagata M; Uchida S
Intern Med; 2015; 54(23):3023-8. PubMed ID: 26631886
[TBL] [Abstract][Full Text] [Related]
19. Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases.
Leung N; Gertz M; Kyle RA; Fervenza FC; Irazabal MV; Eirin A; Kumar S; Cha SS; Rajkumar SV; Lacy MQ; Zeldenrust SR; Buadi FK; Hayman SR; Nasr SH; Sethi S; Ramirez-Alvarado M; Witzig TE; Herrmann SM; Dispenzieri A
Clin J Am Soc Nephrol; 2012 Dec; 7(12):1964-8. PubMed ID: 23024162
[TBL] [Abstract][Full Text] [Related]
20. Serum-free light-chain analysis in diagnosis and management of multiple myeloma and related conditions.
Milani P; Palladini G; Merlini G
Scand J Clin Lab Invest Suppl; 2016; 245():S113-8. PubMed ID: 27467897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
